Halvor Rollag

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Halvor Rollag et al. · American Journal of Transplantation · 2007 · 421 citations

Intravenous Ganciclovir, Transplantation, Cytomegalovirus Disease +4

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

Solbjørg Sagedal, Anders Hartmann, Knut P. Nordal et al. · Kidney International · 2004 · 339 citations

Transplantation, Early Cytomegalovirus Infection, Kidney Transplant +9

The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients

Solbjørg Sagedal, Knut P. Nordal, Anders Hartmann et al. · American Journal of Transplantation · 2002 · 290 citations · Full text

Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation

J. Hjelmes�th, Solbjørg Sagedal, Anders Hartmann et al. · Diabetologia · 2004 · 227 citations · Full text

Transplantation, Kidney Transplant, Diabetes +7

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Alan G. Jardine et al. · American Journal of Transplantation · 2009 · 182 citations

Translational Medicine, Transplantation, Solid Organ Transplantation +5